Case File №
#VI-2026-0171
Loti Labs
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
33 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | A Great | 5 | 7.3 | 6.0 | 8.0 | 16 Mar 2025 |
| Melanotan II | C Okay | 3 | 5.3 | 4.9 | 5.9 | 16 Mar 2025 |
| Tirzepatide | C Okay | 10 | 6.4 | 4.2 | 8.0 | 16 Mar 2025 |
| Semaglutide | D Poor | 4 | 4.9 | 4.6 | 5.0 | 16 Mar 2025 |
| CJC-1295 | E Bad | 5 | 1.5 | 1.1 | 2.0 | 16 Mar 2025 |
| BPC-157 | E Bad | 5 | 3.5 | 2.2 | 4.5 | 16 Mar 2025 |
| AICAR | X N/A | 3 | 4.6 | 4.3 | 4.9 | 23 May 2026 |
| ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 | X N/A | 3 | 4.4 | 3.7 | 5.2 | 21 May 2026 |
| BAC Water | X N/A | 1 | 5.2 | 5.2 | 5.2 | 3 Jun 2025 |
| BPC 500mcg + TB500 500mcg Blend Oral | X N/A | 2 | 4.0 | 2.2 | 4.1 | 24 May 2026 |
| Bronchogen | X N/A | 1 | 4.6 | 4.6 | 4.6 | 3 Jun 2025 |
| Cardiogen | X N/A | 1 | 6.6 | 6.6 | 6.6 | 13 Feb 2025 |
| Dapoxetine | X N/A | 3 | 5.7 | 4.8 | 6.9 | 24 May 2026 |
| Dermorphin | X N/A | 2 | 4.0 | 1.2 | 1.5 | 26 Jan 2026 |
| DNP | X N/A | 2 | 5.5 | 4.7 | 6.2 | 25 May 2026 |
| DSIP | X N/A | 3 | 5.7 | 4.3 | 6.8 | 17 May 2026 |
| Halotestin (Fluoxymesterone) | X N/A | 2 | 4.2 | 4.1 | 4.2 | 19 Jan 2026 |
| Lipo-B 216mg | X N/A | 3 | 4.7 | 3.5 | 7.0 | 17 May 2026 |
| Methylene Blue | X N/A | 2 | 4.1 | 3.0 | 5.2 | 23 May 2026 |
| Minoxidil Oral | X N/A | 2 | 6.6 | 6.4 | 6.7 | 24 May 2026 |
| MOTS-C | X N/A | 1 | 5.2 | 5.2 | 5.2 | 21 May 2025 |
| P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 | X N/A | 3 | 4.6 | 3.1 | 5.4 | 21 May 2026 |
| Pinealon | X N/A | 1 | 6.9 | 6.9 | 6.9 | 8 Jul 2025 |
| PTD-DBM | X N/A | 3 | 4.0 | 1.4 | 6.3 | 23 May 2026 |
| Semax | X N/A | 3 | 6.1 | 3.6 | 7.7 | 17 May 2026 |
| Sleep Blend (GABA 100mg+Histidine 100mg+L-Theanine 50mg+Taurine 100mg+Melatonin 2mg) | X N/A | 3 | 4.9 | 3.3 | 5.9 | 17 May 2026 |
| SNAP-8 | X N/A | 2 | 6.2 | 6.0 | 6.5 | 21 May 2026 |
| T3 (Liothyronine) | X N/A | 1 | 5.7 | 5.7 | 5.7 | 13 Jun 2025 |
| Testosterone Cypionate Raw | X N/A | 3 | 7.3 | 5.4 | 9.3 | 26 Jan 2026 |
| Thymalin | X N/A | 3 | 4.6 | 3.6 | 5.6 | 20 May 2026 |
| Vesugen | X N/A | 3 | 5.2 | 4.5 | 5.8 | 25 May 2026 |
| Winstrol Oil | X N/A | 2 | 5.8 | 4.8 | 6.9 | 26 Jan 2026 |
| YK-11 Raw | X N/A | 3 | 4.1 | 3.0 | 4.9 | 17 May 2026 |
Exhibit II
Evidence Log
68 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Dermorphin | 4.0 C | 20mg | 21.0mg | +5.1% | 96.58% | in4rsn | Lab D | Public |
| 25 May 2026 | Halotestin (Fluoxymesterone) | 4.0 C | 50mg | 49.1mg | -1.7% | 98.08% | qmi3ik | Lab E | Public |
| 25 May 2026 | PTD-DBM | 4.0 C | 20mg | 22.9mg | +14.6% | 98.12% | jbbm7v | Lab F | Community |
| 25 May 2026 | Testosterone Cypionate Raw | 6.7 A | 500g | 503.1g | +0.6% | 99.67% | 2s3pcp | Lab B | Public |
| 25 May 2026 | Testosterone Cypionate Raw | 5.8 B | 10g | 10.4g | +3.5% | 97.49% | lmylfu | Lab G | Public |
| 24 May 2026 | Thymalin | 5.7 B | 2mg | 2.3mg | +15.5% | 96.66% | 7kfy03 | Lab C | Community |
| 24 May 2026 | Dapoxetine | 4.2 C | 20mg | 23.3mg | +16.4% | 99.90% | 2l2tdo | Lab C | Community |
| 24 May 2026 | Sleep Blend (GABA 100mg+Histidine 100mg+L-Theanine 50mg+Taurine 100mg+Melatonin 2mg) | 6.2 A | 300mg/ml | 352.1mg/ml | +17.4% | 98.01% | nzxlwd | Lab B | Community |
| 24 May 2026 | Dermorphin | 6.1 A | 30mg | 30.0mg | -0.1% | 98.92% | q251wk | Lab B | Community |
| 24 May 2026 | PTD-DBM | 4.0 C | 10mg | 11.2mg | +11.8% | 99.76% | 6y1i04 | Lab F | Public |
| 24 May 2026 | YK-11 Raw | 4.0 C | 5g | 5.8g | +16.0% | 98.62% | bzeshw | Lab C | Public |
| 24 May 2026 | ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 | 4.0 C | 5g | 6.1g | +22.8% | 96.99% | rvvify | Lab C | Community |
| 24 May 2026 | P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 | 5.1 B | 5g | 4.7g | -5.4% | 97.67% | ti9qdz | Lab C | Community |
| 24 May 2026 | Thymalin | 4.7 C | 5mg | 5.4mg | +7.8% | 96.91% | 7ixv8i | Lab C | Public |
| 23 May 2026 | AICAR | 5.5 B | 30mg | 26.5mg | -11.8% | 97.58% | nvw1ee | Lab C | Community |
| 23 May 2026 | BPC 500mcg + TB500 500mcg Blend Oral | 4.0 C | 50mg | 62.1mg | +24.1% | 97.17% | 84azr8 | Lab F | Community |
| 23 May 2026 | Lipo-B 216mg | 4.0 C | 200mg/ml | 181.9mg/ml | -9.1% | 98.57% | t4c3hq | Lab A | Community |
| 23 May 2026 | SNAP-8 | 4.3 C | 5mg | 4.3mg | -14.7% | 96.61% | v5sax7 | Lab D | Public |
| 23 May 2026 | BPC 500mcg + TB500 500mcg Blend Oral | 4.0 C | 20mg | 19.0mg | -5.0% | 96.85% | jiu1cd | Lab E | Public |
| 23 May 2026 | DNP | 7.0 A | 100mg | 117.5mg | +17.5% | 96.88% | 5rzafw | Lab D | Public |
| 21 May 2026 | ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 | 5.2 B | 10g | 8.9g | -10.8% | 98.70% | wgr3zt | Lab A | Community |
| 21 May 2026 | Dapoxetine | 5.7 B | 25mg | 28.0mg | +12.2% | 98.10% | hfdajm | Lab G | Public |
| 21 May 2026 | Minoxidil Oral | 7.0 A | 10mg | 11.8mg | +17.5% | 97.54% | tam35h | Lab F | Community |
| 21 May 2026 | P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 | 6.0 A | 5g | 5.2g | +3.4% | 98.53% | ldhxbk | Lab F | Community |
| 20 May 2026 | MOTS-C | 6.4 A | 15mg | 13.2mg | -12.2% | 96.33% | 4fe9mc | Lab F | Public |
| 19 May 2026 | Cardiogen | 7.2 A | 20mg | 18.6mg | -7.1% | 96.66% | 3lgdlx | Lab E | Public |
| 17 May 2026 | Sleep Blend (GABA 100mg+Histidine 100mg+L-Theanine 50mg+Taurine 100mg+Melatonin 2mg) | 6.0 A | 300mg/ml | 282.4mg/ml | -5.9% | 96.97% | y3n174 | Lab F | Community |
| 29 Jan 2026 | Lipo-B 216mg | 4.0 C | 100mg/ml | 93.1mg/ml | -6.9% | 99.03% | 49jtac | Lab B | Public |
| 29 Jan 2026 | Winstrol Oil | 6.2 A | 200mg/ml | 230.0mg/ml | +15.0% | 97.44% | 0m1f3j | Lab G | Public |
| 26 Jan 2026 | AICAR | 4.0 C | 20mg | 24.2mg | +21.1% | 97.72% | miu3v1 | Lab A | Community |
| 26 Jan 2026 | Sleep Blend (GABA 100mg+Histidine 100mg+L-Theanine 50mg+Taurine 100mg+Melatonin 2mg) | 4.0 C | 250mg/ml | 258.0mg/ml | +3.2% | 98.58% | xqwaxx | Lab A | Public |
| 19 Jan 2026 | Dapoxetine | 6.1 A | 100mg | 115.5mg | +15.5% | 99.19% | 5eac9h | Lab G | Community |
| 19 Jan 2026 | YK-11 Raw | 4.4 C | 500g | 596.3g | +19.3% | 98.95% | 8zc3cs | Lab B | Public |
| 9 Jan 2026 | Bronchogen | 5.5 B | 15mg | 13.2mg | -12.1% | 97.01% | 4voqbi | Lab G | Public |
| 7 Jan 2026 | Vesugen | 4.0 C | 2mg | 2.2mg | +12.0% | 99.63% | h8n5a3 | Lab D | Community |
| 6 Jan 2026 | Testosterone Cypionate Raw | 6.3 A | 100g | 114.0g | +14.0% | 96.18% | 9on0ji | Lab D | Public |
| 29 Dec 2025 | DSIP | 4.4 C | 50mg | 52.4mg | +4.8% | 99.45% | w4i3ys | Lab B | Community |
| 12 Dec 2025 | DNP | 4.2 C | 50mg | 49.1mg | -1.9% | 97.80% | 1x08id | Lab A | Community |
| 5 Dec 2025 | Lipo-B 216mg | 5.0 B | 250mg/ml | 308.6mg/ml | +23.4% | 97.11% | mv2mmz | Lab F | Public |
| 5 Dec 2025 | Pinealon | 7.2 A | 15mg | 16.6mg | +11.0% | 97.29% | y9uzob | Lab F | Public |
| 5 Dec 2025 | Vesugen | 6.9 A | 30mg | 35.2mg | +17.4% | 99.77% | wnflgf | Lab B | Public |
| 23 Nov 2025 | ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 | 4.0 C | 100g | 100.0g | -0.0% | 99.93% | kiycob | Lab G | Community |
| 23 Nov 2025 | Methylene Blue | 4.5 C | 25mg | 25.6mg | +2.4% | 98.98% | xm2cst | Lab E | Public |
| 23 Nov 2025 | Semax | 7.9 A | 5mg | 5.1mg | +1.8% | 96.18% | a6e7ka | Lab F | Public |
| 23 Nov 2025 | Semax | 4.4 C | 20mg | 23.4mg | +17.2% | 98.62% | yep478 | Lab C | Public |
| 14 Nov 2025 | DSIP | 7.5 A | 50mg | 48.2mg | -3.7% | 95.50% | jyhpru | Lab C | Community |
| 5 Nov 2025 | AICAR | 4.8 C | 50mg | 54.4mg | +8.7% | 97.22% | 3ibtze | Lab A | Public |
| 5 Nov 2025 | Methylene Blue | 4.0 C | 20mg | 23.6mg | +18.2% | 95.28% | x0jbdc | Lab A | Community |
| 5 Nov 2025 | Minoxidil Oral | 8.0 A | 10mg | 11.2mg | +11.7% | 98.28% | demwum | Lab A | Community |
| 5 Nov 2025 | P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 | 4.8 C | 1g | 1.1g | +7.9% | 95.48% | a5umcl | Lab G | Public |
| 5 Nov 2025 | Semax | 6.6 A | 10mg | 9.3mg | -6.8% | 96.14% | tluo1c | Lab D | Community |
| 5 Nov 2025 | T3 (Liothyronine) | 5.9 B | 10mg | 8.7mg | -13.4% | 99.17% | gvw6zg | Lab D | Public |
| 5 Nov 2025 | Vesugen | 7.2 A | 2mg | 1.8mg | -10.9% | 95.13% | 2opmwu | Lab C | Public |
| 4 Nov 2025 | Halotestin (Fluoxymesterone) | 4.0 C | 10mg | 8.6mg | -13.6% | 96.91% | ifzt2a | Lab F | Community |
| 17 Oct 2025 | DSIP | 4.1 C | 5mg | 5.2mg | +3.4% | 98.31% | 1mcfai | Lab A | Community |
| 17 Oct 2025 | Thymalin | 4.4 C | 30mg | 31.1mg | +3.8% | 99.22% | tibl6d | Lab D | Public |
| 9 Oct 2025 | PTD-DBM | 4.6 C | 2mg | 2.0mg | -2.2% | 98.97% | 9fwtdn | Lab F | Public |
| 9 Oct 2025 | YK-11 Raw | 4.6 C | 5g | 5.0g | +0.4% | 95.02% | zjjfof | Lab B | Public |
| 3 Oct 2025 | BAC Water | 6.8 A | 10mg | 11.3mg | +12.9% | 97.33% | k5v5yf | Lab B | Public |
| 3 Oct 2025 | SNAP-8 | 6.9 A | 30mg | 27.0mg | -9.8% | 96.90% | ywnma0 | Lab A | Public |
| 3 Oct 2025 | Winstrol Oil | 6.2 A | 300mg/ml | 264.4mg/ml | -11.9% | 99.38% | j0w7p4 | Lab E | Public |
| 7 May 2025 | Tirzepatide | X | 4.2 | 5mg | 4.42mg | -11.6% | 99.04% | White Label / Silver Crimp / Black Cap | Lab C |
| 7 May 2025 | Tirzepatide | X | 7.8 | 10mg | 9.48mg | -5.2% | 99.83% | White Label / Silver Crimp / Purple Cap | Lab C |
| 6 May 2025 | Retatrutide | X | 6.0 | 5mg | 5.6mg | +12.0% | 99.91% | White Label / Silver Crimp / Violet Cap | Lab C |
| 5 May 2025 | CJC-1295 | DAC X | 1.3 | 2mg | 1.16mg | -42.0% | 60.95% | White Label / Silver Crimp / Red Cap | Lab B |
| 5 May 2025 | CJC-1295 | DAC X | 1.1 | 2mg | 0.93mg | -53.5% | 54.54% | White Label / Silver Crimp / Red Cap | Lab B |
| 5 May 2025 | BPC-157 | X | 4.1 | 5mg | 4.05mg | -19.0% | 99.51% | White Label / Silver Crimp / Purple Cap | Lab C |
| 27 Mar 2025 | Retatrutide | X | 8.0 | 5mg | 5.07mg | +1.4% | 99.93% | White Label / Silver Crimp / Violet Cap | Lab C |
— END OF EVIDENCE LOG —